Anti-cytokine therapy for prevention of atherosclerosis

被引:29
|
作者
Kirichenko, Tatiana V. [1 ,2 ]
Sobenin, Igor A. [2 ,3 ]
Nikolic, Dragana [4 ]
Rizzo, Manfredi [4 ,5 ]
Orekhov, Alexander N. [1 ,2 ]
机构
[1] Skolkovo Innovat Ctr, Inst Atherosclerosis Res, 4-1-207 Osennaya Str, Moscow 121609, Russia
[2] Inst Gen Pathol & Pathophysiol, 8 Baltiyskaya Str, Moscow 125315, Russia
[3] Russian Cardiol Res & Prod Complex, 15-A 3rd Cherepkovskaya Str, Moscow 121552, Russia
[4] Univ Palermo, Biomed Dept Internal Med & Med Specialties, 141 Via Vespro, I-90127 Palermo, Italy
[5] Euromediterranean Inst Sci & Technol, Via Emerico Amari 123, I-90139 Palermo, Italy
关键词
Atherosclerosis prevention; Anti-cytokine therapy; Inflammation; Herbal preparation; TUMOR-NECROSIS-FACTOR; INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; ANTIINFLAMMATORY THERAPIES; INFLAMMATORY CYTOKINES; MESSENGER-RNA; HEART-DISEASE; MACROPHAGE;
D O I
10.1016/j.phymed.2015.12.002
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Currently a chronic inflammation is considered to be the one of the most important reasons of the atherosclerosis progression. A huge amount of researches over the past few decades are devoted to study the various mechanisms of inflammation in the development of atherosclerotic lesions. Purpose: To review current capabilities of anti-inflammatory therapy for the prevention and treatment of atherosclerosis and its clinical manifestations. Methods: Appropriate articles on inflammatory cytokines in atherosclerosis and anti-inflammatory prevention of atherosclerosis were searched in PubMed Database from their respective inceptions until October 2015. Sections: "The role of inflammatory cytokines in the development of atherosclerotic lesions" describes available data on the possible inflammatory mechanisms of the atherogenesis with a special attention to the role of cytokines. "Modern experience of anti-inflammatory therapy for the treatment of atherosclerosis" describes modern anti-inflammatory preparations with anti-atherosclerotic effect including natural preparations. In "the development of anti-inflammatory herbal preparation for atherosclerosis prevention" an algorithm is demonstrated that includes screening of anti-cytokine activity of different natural products, the development of the most effective combination and estimation of its effect in cell culture model, in animal model of the acute aseptic inflammation and in a pilot clinical trial. A natural preparation "Inflaminat" based on black elder berries (Sambucus nigra L), violet tricolor herb (Viola tricolor L.) and calendula flowers (Calendula officinalis L.) possessing anti-cytokine activity was developed using the designed algorithm. The results of the following 2-year double blind placebo-controlled clinical study show that "Inflaminat" reduces carotid IMT progression, i.e. has anti-atherosclerotic effect. Conclusion: Anti-cytokine therapy may be a promising direction in moderation of atherogenesis, especially when it begins on the early stages of subclinical atherosclerosis. The use of herbal preparations with anti-cytokine mechanism of action is the most perspective for timely prevention of atherosclerosis, as they have no significant side effects and can be prescribed for long-term administration. (C) 2015 Elsevier GmbH. All rights reserved.
引用
收藏
页码:1198 / 1210
页数:13
相关论文
共 50 条
  • [31] Anti-cytokine Ab immune therapy: present status and perspectives
    Zagury, D
    Gallo, RC
    DRUG DISCOVERY TODAY, 2004, 9 (02) : 72 - 81
  • [32] Anti-cytokine therapy in fibrosing alveolitis: Where are we now?
    Millar A.
    Respiratory Research, 2000, 1 (1) : 3 - 5
  • [33] Anti-cytokine therapy and plasma DNA in patients with rheumatoid arthritis
    Laukova, Lucia
    Konecna, Barbora
    Vlkova, Barbora
    Mlynarikova, Vanda
    Celec, Peter
    Stenova, Emoke
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (08) : 1449 - 1454
  • [34] Anti-cytokine therapeutics and infections
    Dinarello, CA
    VACCINE, 2003, 21 : S24 - S34
  • [35] Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
    Wang, Kepeng
    Grivennikov, Sergei I.
    Karin, Michael
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 100 - 103
  • [36] Making anti-cytokine therapy more selective: Studies in mice
    Drutskaya, Marina S.
    Efimov, Grigory A.
    Astrakhantseva, Irina V.
    Kruglov, Andrei A.
    Nedospasov, Sergei A.
    CYTOKINE, 2018, 101 : 33 - 38
  • [37] Anti-cytokine therapy produces response in patients with myelodysplastic syndromes (MDS).
    Raza, A
    Gezer, S
    Gregory, SA
    Venugopal, P
    Kaizer, H
    Dong, LM
    Span, L
    Hines, C
    Thomas, R
    Alvi, S
    Mundle, SD
    Shetty, V
    Borek, R
    Loew, J
    Reza, S
    Robin, EL
    Rifkin, SD
    Alston, D
    Hernandez, BM
    Shah, R
    Hsu, WT
    Dar, S
    Preisler, HD
    BLOOD, 1996, 88 (10) : 2310 - 2310
  • [38] Cytokines Involved in the Pathogenesis of SSc and Problems in the Development of Anti-Cytokine Therapy
    Shima, Yoshihito
    CELLS, 2021, 10 (05)
  • [39] CYTOKINE AND ANTI-CYTOKINE STRATEGIES IN INFLAMMATORY REACTION MODULATION
    DELANNOY, I
    LEKEUX, P
    MIOSSEC, P
    VETERINARY RESEARCH, 1993, 24 (06) : 449 - 467
  • [40] Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis
    Numerof, Robert P.
    Asadullah, Khusru
    BIODRUGS, 2006, 20 (02) : 93 - 103